Product Categories
| Country: | China |
|---|---|
| Tel: | 00-13720134139 +86 -0-15871494362 |
| Mobile: | 13720134139 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Maribavir | C15H19Cl2N3O4 | 176161-24-3 | Details |
| LGD4033 | C14H12F6N2O | 1165910-22-4 | Details |
| Enobosarm/MK2866 | C19H14F3N3O3 | 841205-47-8 | Details |
| Cetuximab | C107H179N35O36S7 | 205923-56-4 | Details |
| Acadesine | C9H14N4O5 | 2627-69-2 | Details |
| Cardarine/GW501516 | C21H18F3NO3S2 | 317318-70-0 | Details |
| Exbivirumab | 569658-80-6 | Details |
| Tefibazumab | 521079-87-8 | Details |
| Urtoxazumab | 502496-16-4 | Details |
| Libivirumab | 569658-79-3 | Details |
| Raxibacumab | 565451-13-0 | Details |
| notuzumab | 635715-01-4 | Details |
| Besilesomab | 537694-98-7 | Details |
| Elsilimomab | 468715-71-1 | Details |
| Pritumumab | 499212-74-7 | Details |
| Belimumab | 356547-88-1 | Details |
| Research Grade Taplitumomab | Details |
| Research Grade Bivatuzumab | Details |
| Vapaliximab | 336801-86-6 | Details |
| Teneliximab | 395639-53-9 | Details |
| reslizumab | 241473-69-8 | Details |
| Ecromeximab | 292819-64-8 | Details |
| Lemalesomab | 250242-54-7 | Details |
| Erlizumab | 211323-03-4 | Details |
| Research Grade Anatumomab | Details |
| Cixutumumab | 947687-12-9 | Details |
| Elotuzumab | 915296-00-3 | Details |
| Farletuzuma | 896723-44-7 | Details |
| Research Grade Pintumomab | Details |
| Research Grade Sibrotuzumab | Details |
| Figitumumab | 943453-46-1 | Details |
| SU5408 | C18H18N2O3 | 15966-93-5 | Details |
| Tucotuzumab Celmoleukin | 339986-90-2 | Details |
| Yttrium (90Y) Tacatuzumab Tetraxetan | 476413-07-7 | Details |
| Volociximab | 558480-40-3 | Details |
| Robatumumab | 934235-44-6 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 | ||||